Want to see GHRS full AI Analyst Report?
ETFs with GH Research (GHRS) Exposure
The following ETFs maintain exposure to GH Research (GHRS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
10 ETFs Hold GH Research (GHRS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in GHRS |
|---|---|---|---|---|---|---|
| PSIL | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | 4.24% | $1.98M | 0.13% |
| EIRL | iShares MSCI Ireland ETF | $77.88M | 0.50% | 1.44% | $1.11M | 0.08% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.77% | $263.92K | 0.02% |
| FPXE | First Trust IPOX Europe Equity Opportunities ETF | $4.80M | 0.70% | 0.23% | $10.95K | <0.01% |
| CBR1 | First Trust IPOX Europe Equity Opportunities UCITS ETF EUR | $1.24M | 0.73% | 0.23% | $2,821.62 | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.09% | $1.26M | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.09% | $110.04K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.07% | $8.29M | 0.58% |
| GERD | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | <0.01% | $59.64K | <0.01% |
| K0MR | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | <0.01% | $59.64K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in GHRS |
|---|---|---|---|---|---|---|
| PSIL | 4.24% | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | $1.98M | 0.13% |
| EIRL | 1.44% | iShares MSCI Ireland ETF | $77.88M | 0.50% | $1.11M | 0.08% |
| BBC | 0.77% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $263.92K | 0.02% |
| FPXE | 0.23% | First Trust IPOX Europe Equity Opportunities ETF | $4.80M | 0.70% | $10.95K | <0.01% |
| CBR1 | 0.23% | First Trust IPOX Europe Equity Opportunities UCITS ETF EUR | $1.24M | 0.73% | $2,821.62 | <0.01% |
| OM3E | 0.09% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $1.26M | 0.09% |
| IBBQ | 0.09% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $110.04K | <0.01% |
| IBB | 0.07% | iShares Biotechnology ETF | $11.52B | 0.44% | $8.29M | 0.58% |
| GERD | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | $59.64K | <0.01% |
| K0MR | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | $59.64K | <0.01% |
Popular ETF Comparisons
GHRS ETF Exposure FAQ
What ETFs hold GH Research stock?
GH Research (GHRS) is currently held by 10 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to GHRS include iShares (IBB), AdvisorShares (PSIL) and iShares (DE:OM3E).
Which ETF has the largest exposure to GHRS?
The ETF with the largest exposure to GHRS is iShares (IBB), with approximately $8.29M in market value exposure.
How much GHRS stock is held by ETFs?
ETFs currently hold approximately $13.15M worth of GH Research (GHRS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.